Viewing Study NCT04162327


Ignite Creation Date: 2025-12-25 @ 5:12 AM
Ignite Modification Date: 2026-02-24 @ 8:50 AM
Study NCT ID: NCT04162327
Status: COMPLETED
Last Update Posted: 2023-10-24
First Post: 2019-10-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase Ia/Ib Study of IBI315 in Patients With HER2-expressing Advanced Solid Tumor
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module